The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
Prostate Cancer: Lifestyle Recommendations During Androgen Deprivation Therapy
Prostate Cancer: Lifestyle Recommendations During Androgen Deprivation Therapy
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Alleviating Anemia in Myelofibrosis: New Therapeutic Avenues
Alleviating Anemia in Myelofibrosis: New Therapeutic Avenues
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
Patient-Centered Insights for Advanced Prostate Cancer Treatment
Patient-Centered Insights for Advanced Prostate Cancer Treatment
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
mCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
mCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management